KLHL14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.66133814775094E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.99200722162641E-16 |
Normal-vs-Stage2 |
9.99200722162641E-16 |
Normal-vs-Stage3 |
4.44089209850063E-16 |
Normal-vs-Stage4 |
6.66133814775094E-16 |
Stage1-vs-Stage2 |
9.700000E-01 |
Stage1-vs-Stage3 |
7.796100E-02 |
Stage1-vs-Stage4 |
6.972800E-01 |
Stage2-vs-Stage3 |
2.329000E-01 |
Stage2-vs-Stage4 |
7.729000E-01 |
Stage3-vs-Stage4 |
4.080600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.44089209850063E-16 |
Normal-vs-AfricanAmerican |
1.63158375698913E-12 |
Normal-vs-Asian |
1.72084568816899E-14 |
Caucasian-vs-AfricanAmerican |
2.883900E-02 |
Caucasian-vs-Asian |
5.330800E-01 |
AfricanAmerican-vs-Asian |
6.144600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.88178419700125E-16 |
Normal-vs-Female |
6.66133814775094E-16 |
Male-vs-Female |
3.458800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.88578058618805E-15 |
Normal-vs-Age(41-60Yrs) |
5.55111512312578E-16 |
Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
Normal-vs-Age(81-100Yrs) |
1.62458935193399E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.408400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.678400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.230650E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.996830E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.312300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.880200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.03925765163149E-12 |
Normal-vs-Grade 2 |
1.62558855265615E-12 |
Normal-vs-Grade 3 |
4.44089209850063E-16 |
Normal-vs-Grade 4 |
1.6251444634463E-12 |
Grade 1-vs-Grade 2 |
6.733400E-01 |
Grade 1-vs-Grade 3 |
3.863200E-01 |
Grade 1-vs-Grade 4 |
5.140200E-01 |
Grade 2-vs-Grade 3 |
1.512230E-02 |
Grade 2-vs-Grade 4 |
3.070000E-01 |
Grade 3-vs-Grade 4 |
2.355400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62458935193399E-12 |
Normal-vs-ccB subtype |
1.62558855265615E-12 |
ccA subtype-vs-ccB subtype |
2.160800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.55111512312578E-16 |
Normal-vs-N1 |
1.62669877568078E-12 |
N0-vs-N1 |
4.066000E-01 |
|
|